Pulmatrix (PULM) News
NASDAQ: PULMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.27-0.15 (-10.56%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PULM news summary
We found 4 recent headlines mentioning Pulmatrix (PULM): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, PR Newswire. PULM is making an outsized move today, down 10.56% at $1.27, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Pulmatrix Q3 Loss Widens; Expects Eos SENOLYTIX Merger To Close In November; Stock Up", was published by Nasdaq on Nov 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Pulmatrix headlines
- Pulmatrix Q3 Loss Widens; Expects Eos SENOLYTIX Merger To Close In November; Stock Up(RTTNews) - Pulmatrix, Inc. (PULM), a biopharmaceutical company, announced its third-quarter 2026 financial results, which reflected a wider net loss. The company also provided a corporate update on…NasdaqPULM, ET
- Pulmatrix, Inc. Reports Third Quarter 2026 Financial Results and Progress on Eos SENOLYTIX MergerPulmatrix, Inc. announced its third quarter 2026 financial results and provided a progress update on its proposed merger with Eos SENOLYTIX, Inc. The company has obtained SEC effectiveness on its…NasdaqPULM, BF.A
- Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on MergerMerger with Eos SENOLYTIX expected to close by end of the year FRAMINGHAM, Mass., Nov. 17, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix", the "Company" or "our") (Nasdaq: PULM), a…PR Newswire
- Pulmatrix, Inc. Stockholders Approve Merger-Related Proposals and Reverse Stock SplitPulmatrix, Inc. held a special meeting of stockholders on October 26, 2026, in connection with its proposed merger with Eos SENOLYTIX, Inc. Stockholders approved the issuance of shares of Pulmatrix…NasdaqPULM, BIO.B